Paolo Amerio Selected Research

Paolo Amerio Research Topics

Disease

15	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2023 - 03/2004
7	Atopic Dermatitis (Atopic Eczema) 05/2024 - 03/2003
6	Neoplasms (Cancer) 01/2023 - 03/2002
4	Infections 01/2023 - 03/2003
4	Inflammation (Inflammations) 05/2021 - 03/2003
3	Skin Diseases (Skin Disease) 06/2023 - 03/2003
3	COVID-19 01/2023 - 01/2021
2	Ulcer 04/2024 - 10/2011
2	Melanoma (Melanoma, Malignant) 01/2022 - 01/2019
2	Hypersensitivity (Allergy) 02/2021 - 03/2003
2	Psoriatic Arthritis 02/2021 - 01/2014
2	Basal Cell Carcinoma (Rodent Ulcer) 08/2020 - 07/2011
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 08/2020 - 01/2017
1	Leg Ulcer 04/2024
1	Prurigo 10/2023
1	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 10/2023
1	Benign Familial Pemphigus (Hailey Hailey Disease) 12/2022
1	Eczema 09/2022
1	Hyperhidrosis 01/2022
1	Mycosis Fungoides 07/2021
1	Body Weight (Weight, Body) 02/2021
1	Crohn Disease (Crohn's Disease) 02/2021
1	Ulcerative Colitis 02/2021
1	Cytokine Release Syndrome 01/2021
1	Multiple Organ Failure (MODS) 01/2021
1	Insulin Resistance 10/2020
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 10/2020
1	Breast Neoplasms (Breast Cancer) 09/2020
1	Hypertension (High Blood Pressure) 09/2020
1	Keratoacanthoma 08/2020
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2017
1	Lung Neoplasms (Lung Cancer) 01/2017
1	Colorectal Neoplasms (Colorectal Cancer) 01/2017
1	Squamous Cell Neoplasms (Squamous Cell Cancer) 01/2017
1	Necrosis 02/2016
1	Actinic Keratosis 08/2015
1	Latent Tuberculosis 08/2013
1	Lymphoma (Lymphomas) 10/2012
1	Calciphylaxis 10/2011
1	Livedo Reticularis 10/2011

Drug/Important Bio-Agent (IBA)

6	CytokinesIBA 10/2021 - 03/2003
4	secukinumabIBA 01/2023 - 01/2021
2	dupilumabIBA 01/2024 - 10/2023
2	Methotrexate (Mexate)FDA LinkGeneric 06/2023 - 08/2020
2	Type A Botulinum Toxins (Botox)FDA Link 12/2022 - 01/2022
2	Monoclonal AntibodiesIBA 10/2021 - 02/2021
2	ChemokinesIBA 01/2019 - 03/2003
1	Interleukin-6 (Interleukin 6)IBA 04/2024
1	AntioxidantsIBA 04/2024
1	VaccinesIBA 01/2023
1	MicroRNAs (MicroRNA)IBA 01/2023
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 12/2022
1	Dapsone FDA Link 12/2022
1	Immunoglobulin A (IgA)IBA 09/2022
1	EmollientsIBA 04/2022
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2022
1	Growth Hormone (Somatotropin)IBA 01/2022
1	Starch (Cornstarch)IBA 01/2022
1	IodineIBA 01/2022
1	Interleukin-17 (Interleukin 17)IBA 10/2021
1	Peptide Hydrolases (Proteases)FDA Link 05/2021
1	Interleukin-23 (Interleukin 23)IBA 02/2021
1	guselkumabIBA 02/2021
1	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 01/2021
1	Insulin (Novolin)FDA Link 10/2020
1	Peptide Hormones (Polypeptide Hormones)IBA 10/2020
1	AdiponectinIBA 10/2020
1	AdipokinesIBA 10/2020
1	Nicotinamide PhosphoribosyltransferaseIBA 10/2020
1	Glucose (Dextrose)FDA LinkGeneric 10/2020
1	Blood Group Antigens (Blood Groups)IBA 09/2020
1	Interleukin-10 (Interleukin 10)IBA 01/2019
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	Cetuximab (Erbitux)FDA Link 01/2017
1	ErbB Receptors (EGF Receptor)IBA 01/2017
1	Tyrosine Kinase InhibitorsIBA 01/2017
1	AfatinibIBA 01/2017
1	Gefitinib (Iressa)FDA Link 01/2017
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2017
1	Caspase 8 (Caspase-8)IBA 02/2016
1	LigandsIBA 02/2016
1	Adalimumab (Humira)FDA Link 12/2013
1	Infliximab (Remicade)FDA Link 12/2013
1	Etanercept (Enbrel)FDA Link 12/2013
1	ThymopentinIBA 10/2012
1	CalciumIBA 10/2011
1	sodium thiosulfate FDA Link 10/2011
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2011
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 06/2010
1	Bio-OssIBA 06/2010

Therapy/Procedure

12	Therapeutics 05/2024 - 03/2004
3	Photochemotherapy (Photodynamic Therapy) 12/2022 - 03/2007
3	Biological Therapy 01/2021 - 08/2013
2	Drug Therapy (Chemotherapy) 08/2020 - 01/2017
1	Immunotherapy 05/2024
1	Complementary Therapies (Alternative Medicine) 05/2024
1	Immunomodulation 11/2021
1	Tattooing 02/2021
1	Phototherapy (Light Therapy) 01/2021
1	Chemoprevention 08/2013